HemaSphere (Aug 2023)
P1424: ONE-YEAR FOLLOW-UP OF A PHASE 2 STUDY OF MITAPIVAT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR THE TREATMENT OF SICKLE CELL DISEASE
- Myrthe van Dijk,
- Minke Rab,
- Brigitte van Oirschot,
- Jennifer Bos,
- Cleo Derichs,
- Anita Rijneveld,
- Marjon Cnossen,
- Erfan Nur,
- Bart Biemond,
- Marije Bartels,
- Judith Jans,
- Wouter van Solinge,
- Roger Schutgens,
- Richard Van Wijk,
- Eduard van Beers
Affiliations
- Myrthe van Dijk
- 1 University Medical Center Utrecht, Utrecht, The Netherlands
- Minke Rab
- 1 University Medical Center Utrecht, Utrecht, The Netherlands
- Brigitte van Oirschot
- 1 University Medical Center Utrecht, Utrecht, The Netherlands
- Jennifer Bos
- 1 University Medical Center Utrecht, Utrecht, The Netherlands
- Cleo Derichs
- 1 University Medical Center Utrecht, Utrecht, The Netherlands
- Anita Rijneveld
- 2 Erasmus University Medical Center, Rotterdam, The Netherlands
- Marjon Cnossen
- 2 Erasmus University Medical Center, Rotterdam, The Netherlands
- Erfan Nur
- 3 Amsterdam University Medical Center, Amsterdam, The Netherlands
- Bart Biemond
- 3 Amsterdam University Medical Center, Amsterdam, The Netherlands
- Marije Bartels
- 1 University Medical Center Utrecht, Utrecht, The Netherlands
- Judith Jans
- 1 University Medical Center Utrecht, Utrecht, The Netherlands
- Wouter van Solinge
- 1 University Medical Center Utrecht, Utrecht, The Netherlands
- Roger Schutgens
- 1 University Medical Center Utrecht, Utrecht, The Netherlands
- Richard Van Wijk
- 1 University Medical Center Utrecht, Utrecht, The Netherlands
- Eduard van Beers
- 1 University Medical Center Utrecht, Utrecht, The Netherlands
- DOI
- https://doi.org/10.1097/01.HS9.0000972584.29706.31
- Journal volume & issue
-
Vol. 7
p. e2970631
Abstract
No abstracts available.
